Inventor · disambiguated record
David A. Claremon
Also filed as: CLAREMON DAVID · CLAREMON DAVID A · CLAREMON DAVID ALAN
150 granted patents·23 pending applications·2,090 citations·filing 1979–2025
99Inventor score
Files withMERCK & CO INC80VITAE PHARMACEUTICALS INC23CLAREMON DAVID A19VITAE PHARMACEUTICALS LLC18BALDWIN JOHN J14
Top patents by PatentIndex Score
173 records- 0197US9481674B1Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Nov 1, 2016·21 cites·6 claims
- 0297US5717100ASubstituted imidazoles having anti-cancer and cytokine inhibitory activityMERCK & CO INC·Filed 1996·Granted Feb 10, 1998·116 cites·33 claims
- 0397US5215989ANitrogen-containing heterocyclic compounds as class III antiarrhythmic agentsMERCK & CO INC·Filed 1991·Granted Jun 1, 1993·108 cites·11 claims
- 0497US5030644AImidazole compounds and their use as transglutaminase inhibitorsMERCK & CO INC·Filed 1989·Granted Jul 9, 1991·72 cites·8 claims
- 0596US5206240ANitrogen-containing spirocyclesMERCK & CO INC·Filed 1991·Granted Apr 27, 1993·77 cites·4 claims
- 0696US5032598ANitrogens containing heterocyclic compounds as class III antiarrhythmic agentsMERCK & CO INC·Filed 1989·Granted Jul 16, 1991·58 cites·9 claims
- 0795US11479557B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Oct 25, 2022·4 cites·23 claims
- 0895US9663515B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·13 cites·15 claims
- 0995US8242111B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Aug 14, 2012·36 cites·24 claims
- 1095US8138178B2Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Mar 20, 2012·37 cites·24 claims
- 1195US5633247ANitrogen-containing spirocyclesMERCK & CO INC·Filed 1995·Granted May 27, 1997·73 cites·10 claims
- 1295US5633251AN-2,3-dihydro-1-(2-propyl)-2-oxo-5-phenyl-1h-1,4-benzodiazepinesMERCK & CO INC·Filed 1995·Granted May 27, 1997·90 cites·11 claims
- 1394US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 1494US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 1593US10399976B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2018·Granted Sep 3, 2019·11 cites·20 claims
- 1693US9868748B2Thiazolopyrrolidine inhibitors of ROR- γVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·13 cites·19 claims
- 1793US9796710B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·12 cites·14 claims
- 1893US5859041ASubstituted imidazoles having cytokine inhibitory activityMERCK & CO INC·Filed 1997·Granted Jan 12, 1999·135 cites·24 claims
- 1993US5595990AAntiarrhythmic benzodiazepinesMERCK & CO INC·Filed 1995·Granted Jan 21, 1997·61 cites·10 claims
- 2093US5389631AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1993·Granted Feb 14, 1995·58 cites·11 claims
- 2192US10087184B2Dihydropyrrolopyridine inhibitors of RORγVITAE PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·10 cites·13 claims
- 2292US8202857B21,3-oxazepan-2-one and 1,3-diazepan-2-one inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Jun 19, 2012·21 cites·75 claims
- 2391US12312359B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2022·Granted May 27, 2025·1 cites·15 claims
- 2491US10683302B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jun 16, 2020·9 cites·28 claims
- 2591US8440658B2Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted May 14, 2013·16 cites·19 claims
- 2690US6870055B2Isoquinolinone potassium channels inhibitorsMERCK & CO INC·Filed 2001·Granted Mar 22, 2005·28 cites·10 claims
- 2790US6316474B12-benzyl and 2-heteroaryl benzimidazole NMDA/NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Nov 13, 2001·43 cites·13 claims
- 2889US7858624B2Piperidine and morpholine renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Dec 28, 2010·7 cites·4 claims
- 2989US7754737B2Diaminoalkane aspartic protease inhibitorsVITAE PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·16 cites·10 claims
- 3088US10899758B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2017·Granted Jan 26, 2021·6 cites·25 claims
- 3188US10301261B2Substituted indoles as modulators of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2016·Granted May 28, 2019·6 cites·22 claims
- 3288US7872028B2Diaminopropanol renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Jan 18, 2011·14 cites·10 claims
- 3387US10807980B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Oct 20, 2020·4 cites·20 claims
- 3487US7592360B23-fluoro-piperidines as NMDA/NR2B antagonistsMERCK & CO INC·Filed 2004·Granted Sep 22, 2009·18 cites·32 claims
- 3586US11535614B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Dec 27, 2022·1 cites·20 claims
- 3685US11739085B2Inhibitors of the menin-MLL interactionVITAE PHARMACEUTICALS LLC·Filed 2020·Granted Aug 29, 2023·1 cites·21 claims
- 3785US8633212B2Inhibitors of beta-secretaseCACATIAN SALVACION·Filed 2010·Granted Jan 21, 2014·10 cites·22 claims
- 3885US6376530B1Cyclic amidines useful as NMDA NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Apr 23, 2002·22 cites·17 claims
- 3985US5098707AImidazole compounds and their use as transglutaminase inhibitorsMERCK & CO INC·Filed 1991·Granted Mar 24, 1992·29 cites·8 claims
- 4084US6403596B1Substituted pyridones having cytokine inhibitory activityMERCK & CO INC·Filed 2000·Granted Jun 11, 2002·14 cites·4 claims
- 4184US5032604AClass III antiarrhythmic agentsMERCK & CO INC·Filed 1989·Granted Jul 16, 1991·18 cites·7 claims
- 4283US8575156B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2008·Granted Nov 5, 2013·5 cites·20 claims
- 4383US7053089B2N-substituted nonaryl-heterocyclic NMDA/NR2B antagonistsMERCK & CO INC·Filed 2002·Granted May 30, 2006·13 cites·40 claims
- 4483US5112824ABenzofuran compounds as class III antiarrhythmic agentsMERCK & CO INC·Filed 1991·Granted May 12, 1992·25 cites·6 claims
- 4583US4609494A5-acetyl-3,4,5,6-tetrahydro-4-oxo-2,6-methano-2H-1,3,5-benzothiazocine(benzodiazocine)-11-carboxylates useful as calcium channel blockersMERCK & CO INC·Filed 1985·Granted Sep 2, 1986·18 cites·6 claims
- 4682US10829448B2Substituted benzoimidazoles as modulators of ROR-γVITAE PHARMACEUTICALS LLC·Filed 2019·Granted Nov 10, 2020·1 cites·6 claims
- 4782US8569292B2Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1CLAREMON DAVID A·Filed 2009·Granted Oct 29, 2013·5 cites·7 claims
- 4881US6476041B11,4 substituted piperidinyl NMDA/NR2B antagonistsMERCK & CO INC·Filed 2000·Granted Nov 5, 2002·16 cites·9 claims
- 4981US6083949ASubstituted imidazoles having anti-cancer and cytokine inhibitory activityMERCK & CO INC·Filed 1998·Granted Jul 4, 2000·28 cites·15 claims
- 5081US5821241AFibrinogen receptor antagonistsMERCK & CO INC·Filed 1994·Granted Oct 13, 1998·21 cites·16 claims
Showing the top 50 of 173 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →